Novo Nordisk plans to invest $4.1 billion to build a second fill and finishing manufacturing facility in Clayton, N.C., as demand for weight-loss drugs show no signs of letting up.
Related Posts
LVMH Billionaire Bernard Arnault, the ‘Shark’ and a Den of Spies Laid Bare in Paris Courtroom
Arnault sought to distance himself from what prosecutors allege was a yearslong intelligence-gathering operation that targeted his foes.
Canada Approves Glencore-Led Deal for Teck Coal Assets
Canada approved a Glencore-led $9 billion deal to acquire coal assets from Teck Resources, after officials secured commitments from both companies about additional investment in […]
Auto & Transport Roundup: Market Talk
Find insight on XPeng, Capital A and more in the latest Market Talks covering the Auto and Transport sector.